Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is 0.00% as of the fiscal period ended Sunday, April 30, 2017.
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
0.00%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$5.21M
EBITDA Margin
-271.50%
TTM Avg
-294.22%
3Y Avg
-453.19%
5Y Avg
-366.18%
Market Cap
$5.20M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.09M
EBITDA Margin
-2579.35%
TTM Avg
-2579.35%
3Y Avg
-2089.74%
5Y Avg
-2089.74%
Market Cap
$5.11M
EBITDA Margin
-4837.99%
TTM Avg
-4449.42%
3Y Avg
-4104.15%
5Y Avg
-4023.55%
Market Cap
$5.01M
EBITDA Margin
-8.85%
TTM Avg
9.13%
3Y Avg
18.32%
5Y Avg
18.32%
Market Cap
$5.66M
EBITDA Margin
-23296.89%
TTM Avg
-13717.94%
3Y Avg
-7355.60%
5Y Avg
-5953.70%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.27M | 0.00% | N/A | N/A | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | N/A | N/A | N/A | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.21M | -271.50% | -294.22% | -453.19% | -366.18% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.20M | N/A | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.09M | -2579.35% | -2579.35% | -2089.74% | -2089.74% |
| Imunon, Inc. (IMNN)vs › | $5.11M | -4837.99% | -4449.42% | -4104.15% | -4023.55% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | -8.85% | 9.13% | 18.32% | 18.32% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.57M | N/A | N/A | N/A | N/A |
| enVVeno Medical Corporation (NVNO)vs › | $5.66M | -23296.89% | -13717.94% | -7355.60% | -5953.70% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | -1127.44% | -14514.89% | -11694.21% | -11694.21% |
Gross Margin
0.0%
EBITDA Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2017-04-30 | 0.00% |
| 2017-01-31 | 0.00% |
